Table 3. Signaling pathway enrichment analysis of differentially expressed genes in PABC.
| DEGs | Biological pathway | Count | P-value | Mapped gene names |
|---|---|---|---|---|
| Up-regulated | Fatty acid activation | 2 | 0.00 | ACSBG1, SL6 |
| FGF signaling pathway | 3 | 0.00 | STAT5B, CG1, MP9 | |
| LPA receptor mediated events | 4 | 0.00 | PLCG1, XN, DCY7, MP9 | |
| Cell-extracellular matrix interactions | 2 | 0.00 | PARVB, XN | |
| CXCR4-mediated signaling events | 5 | 0.00 | STAT5B, LCG1, XN, TPN7, MP9 | |
| EGFR interacts with phospholipase C-gamma | 2 | 0.01 | PLCG1, DCY7 | |
| Signaling by EGFR | 3 | 0.02 | PLCG1, XN, DCY7 | |
| Chemokine receptors bind chemokines | 2 | 0.02 | CXCR5, XCL13 | |
| E-cadherin signaling in the nascent adherens junction | 5 | 0.02 | STAT5B, LCG1, DCY7, TGB7, MMP9 | |
| IL6-mediated signaling events | 2 | 0.03 | IRF1, TNFSF11 | |
| Down-regulated | Activation of DNA fragmentation factor | 2 | 0.00 | HMGB1, KPNA1 |
| Apoptosis induced DNA fragmentation | 2 | 0.00 | HMGB1, KPNA1 | |
| Valine degradation I | 2 | 0.00 | ACADSB, HIBADH | |
| Apoptotic execution phase | 3 | 0.00 | HMGB1, KPNA1, DNM1L | |
| Notch signaling pathway | 4 | 0.00 | AR, NCOR1, RAB11A, MIB1 | |
| Branched-chain amino acid catabolism | 2 | 0.00 | ACADSB, HIBADH | |
| PIP3 activates AKT signaling | 2 | 0.01 | AKT1S1, CREB1 | |
| Glutamate biosynthesis II | 1 | 0.01 | GLUD1 | |
| PI-3K cascade | 2 | 0.02 | AKT1S1, CREB1 | |
| AKT-mediated inactivation of FOXO1A | 1 | 0.02 | CREB1 |
Count: the number of enriched genes in each term.